Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial

Autores: Moore, K. N.; Colombo, N.; Scambia, G. ; Kim, B. G.; Oaknin, A.; Friedlander, M. ; Lisyanskaya, A. ; Floquet, A. ; Leary, A. ; Sonke, G. S. ; Gourley, C. ; Banerjee, S. ; Oza, A. M.; González Martín, Antonio; Aghajanian, C.; Bradley, W. ; Lowe, E. S.; Bloomfield, R.; DiSilvestro, P.